| 2004S-0170 - Medicare Prescription Drug, Improvement, and Modernization Act of 2003, Section 1013: Suggest Priority Topics for Research|
|FDA Comment Number :||EC5|
|Submitter :||Ms. Catherine Benavidez Clayton||Date & Time:||05/03/2004 05:05:50|
|Organization :||National Association of Hispanic Nurses/ Colorado|
|Health Care Association|
| 1.Cost-effective studies often mean 'cheapest', and hence may lead to rationing and limiting options for providers.
2.Meaningful research for review regarding culturally competent design implementations for Latino's is not possible because of a lack of research with this diverse population. The body of 'evidence' is just not available.
Raising new barriers to patient access will only perpetuate further 'health disparities'.
3.Finally, restricting access throught this process does not take into account the indirect costs, such as those related to loss of employment.